Literature DB >> 3292244

Glycogen storage disease: recommendations for treatment.

J Fernandes1, J V Leonard, S W Moses, M Odièvre, M di Rocco, J Schaub, G P Smit, K Ullrich, P Durand.   

Abstract

A workshop was held on "Aspects of treatment of patients with glycogen storage disease" within the framework of the Concerted Action "Inborn errors of metabolism" of the European Communities. Consensus was reached on the main issues of treatment of patients with deficiency of glucose-6-phosphatase, glucose-6-phosphate translocase, debranching enzyme, liver phosphorylase and phosphorylase-b-kinase. The resulting recommendations are reported.

Entities:  

Mesh：

Year:  1988        PMID： 3292244     DOI： 10.1007/bf00442683

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  18 in total

1.  Hepatorenal glycogenosis (type I glycogenosis) and carcinoma of the liver.

Authors:  F Zangeneh; G A Limbeck; B I Brown; J R Emch; M M Arcasoy; V E Goldenberg; V C Kelley
Journal:  J Pediatr       Date:  1969-01       Impact factor: 4.406

2.  Hyperlipemia in children with liver glycogen disease.

Authors:  J Fernandes; N A Pikaar
Journal:  Am J Clin Nutr       Date:  1969-05       Impact factor: 7.045

3.  Hexose and protein tolerance tests in children with liver glycogenosis caused by a deficiency of the debranching enzyme system.

Authors:  J Fernandes; J H van de Kamer
Journal:  Pediatrics       Date:  1968-05       Impact factor: 7.124

4.  Hypoglycaemia complicating feeding regimens for glycogen-storage disease.

Authors:  J V Leonard; D B Dunger
Journal:  Lancet       Date:  1978-12-02       Impact factor: 79.321

5.  Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy.

Authors:  A E Slonim; R A Coleman; W S Moses
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

6.  Haematological findings in type Ib glycogen storage disease before and after portacaval shunt.

Authors:  L Corbeel; M Boogaerts; G Van den Berghe; M C Everaerts; G Marchal; R Eeckels
Journal:  Eur J Pediatr       Date:  1983 Jun-Jul       Impact factor: 3.183

7.  Neutropenia and impaired neutrophil function in glycogenosis type Ib.

Authors:  M Di Rocco; C Borrone; F Dallegri; G Frumento; F Patrone
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Intragastric feeding in type I glycogen storage disease: factors affecting the control of lactic acidemia.

Authors:  C A Stanley; J L Mills; L Baker
Journal:  Pediatr Res       Date:  1981-12       Impact factor: 3.756

Review 9.  Glycogen storage disease type Ib.

Authors:  J Schaub; K Heyne
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

10.  Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy.

Authors:  P Parker; I Burr; A Slonim; F K Ghishan; H Greene
Journal:  Gastroenterology       Date:  1981-09       Impact factor: 22.682
View more
  9 in total

1.  The gene for glycogen-storage disease type 1b maps to chromosome 11q23.

Authors:  B Annabi; H Hiraiwa; B C Mansfield; K J Lei; T Ubagai; M H Polymeropoulos; S W Moses; R Parvari; E Hershkovitz; H Mandel; M Fryman; J Y Chou
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

2.  Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies.

Authors:  Katalin M Ross; Iris A Ferrecchia; Kathryn R Dahlberg; Monika Dambska; Patrick T Ryan; David A Weinstein
Journal:  Adv Nutr       Date:  2020-03-01       Impact factor: 8.701

3.  Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency.

Authors:  A Nakai; Y Shigematsu; T Takano; Y Kikawa; M Sudo
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

4.  The long-term outcome of patients with glycogen storage diseases.

Authors:  G P Smit; J Fernandes; J V Leonard; E E Matthews; S W Moses; M Odievre; K Ullrich
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

5.  Nutritional deficiencies in a patient with glycogen storage disease type Ib.

Authors:  P S Kishnani; A Boney; Y T Chen
Journal:  J Inherit Metab Dis       Date:  1999-10       Impact factor: 4.982

6.  Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia.

Authors:  David A Weinstein; Catherine E Correia; Thomas Conlon; Andrew Specht; John Verstegen; Karine Onclin-Verstegen; Martha Campbell-Thompson; Gurmeet Dhaliwal; Layla Mirian; Holly Cossette; Darin J Falk; Sean Germain; Nathalie Clement; Stacy Porvasnik; Laurie Fiske; Maggie Struck; Harvey E Ramirez; Juan Jordan; Karl Andrutis; Janice Y Chou; Barry J Byrne; Cathryn S Mah
Journal:  Hum Gene Ther       Date:  2010-07       Impact factor: 5.695

Review 7.  Glycogen storage disease type Ia in canines: a model for human metabolic and genetic liver disease.

Authors:  Andrew Specht; Laurie Fiske; Kirsten Erger; Travis Cossette; John Verstegen; Martha Campbell-Thompson; Maggie B Struck; Young Mok Lee; Janice Y Chou; Barry J Byrne; Catherine E Correia; Cathryn S Mah; David A Weinstein; Thomas J Conlon
Journal:  J Biomed Biotechnol       Date:  2011-01-03

8.  Glycogen storage disease type III: modified Atkins diet improves myopathy.

Authors:  Sebene Mayorandan; Uta Meyer; Hans Hartmann; Anibh Martin Das
Journal:  Orphanet J Rare Dis       Date:  2014-11-28       Impact factor: 4.123

9.  Diurnal variability of glucose tetrasaccharide (Glc4) excretion in patients with glycogen storage disease type III.

Authors:  Sarah P Young; Aleena Khan; Ela Stefanescu; Andrea M Seifts; Ghada Hijazi; Stephanie Austin; Priya S Kishnani
Journal:  JIMD Rep       Date:  2020-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.